Search results
Showing 8506 to 8520 of 9043 results
Discontinued Reference number: GID-TA10525
Discontinued Reference number: GID-TA10568
Discontinued Reference number: GID-TA10185
In development Reference number: GID-TAG388 Expected publication date: TBC
In development Reference number: GID-TAG406 Expected publication date: TBC
Avelumab for previously treated platinum-resistant ovarian cancer [ID1497]
In development Reference number: GID-TA10404 Expected publication date: TBC
In development Reference number: GID-TA10483 Expected publication date: TBC
Discontinued Reference number: GID-TA10583
In development Reference number: GID-TA10607 Expected publication date: TBC
In development Reference number: GID-TA10747 Expected publication date: TBC
Ipatasertib with abiraterone and prednisone for hormone-relapsed metastatic prostate cancer [ID3889]
Discontinued Reference number: GID-TA10779
Discontinued Reference number: GID-TA10841
In development Reference number: GID-TA11663 Expected publication date: TBC
In development Reference number: GID-TA11281 Expected publication date: TBC
This guidance has been withdrawn because Cartiva Synthetic Cartilage Implant (SCI) has been recalled, and the evidence for this guidance was based solely on Cartiva SCI. More information is available in the field safety notice issued by Stryker. Surgeons are advised not to implant this device, to return any unused devices to Stryker and to consider reviewing any patients who have had Cartiva SCI. NICE will consider issuing new guidance on synthetic cartilage implant insertion for first metatarsophalangeal joint osteoarthritis (hallux rigidus) if evidence using an appropriately CE-marked device becomes available.